SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-069992
Filing Date
2023-06-09
Accepted
2023-06-09 17:11:01
Documents
15
Period of Report
2023-06-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318330d1_8k.htm   iXBRL 8-K 35416
2 EXHIBIT 5.1 tm2318330d1_ex5-1.htm EX-5.1 11186
6 GRAPHIC tm2318330d1_ex5-1img002.jpg GRAPHIC 2660
7 GRAPHIC tm2318330d1_ex5-1img003.jpg GRAPHIC 1289
  Complete submission text file 0001104659-23-069992.txt   235521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mist-20230607.xsd EX-101.SCH 3054
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20230607_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20230607_pre.xml EX-101.PRE 22609
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2318330d1_8k_htm.xml XML 3875
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 231006282
SIC: 2834 Pharmaceutical Preparations